Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Healthtrust
McKinsey
Federal Trade Commission
US Department of Justice
Harvard Business School
Cantor Fitzgerald
Chubb
Covington
US Army

Generated: August 17, 2017

DrugPatentWatch Database Preview

INFUMORPH Drug Profile

« Back to Dashboard

What is the patent landscape for Infumorph, and when can generic versions of Infumorph launch?

Infumorph is a drug marketed by West-ward Pharms Int and is included in one NDA.

The generic ingredient in INFUMORPH is morphine sulfate. There are twenty-three drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

Summary for Tradename: INFUMORPH

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list10
Clinical Trials: see list3
Patent Applications: see list9,727
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:INFUMORPH at DailyMed

Pharmacology for Tradename: INFUMORPH

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
INFUMORPH
morphine sulfate
INJECTABLE;INJECTION018565-003Jul 19, 1991RXYesYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
INFUMORPH
morphine sulfate
INJECTABLE;INJECTION018565-004Jul 19, 1991RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
US Department of Justice
Julphar
Boehringer Ingelheim
Citi
US Army
AstraZeneca
Cerilliant
Federal Trade Commission
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot